Clinical trial
Treatment With TNF Blockade, Infliximab, in Patients With Myositis
NCT00443222 · Karolinska Institutet, Other · Completed
Key facts
| NCT number | NCT00443222 |
|---|---|
| Title | Treatment With TNF Blockade, Infliximab, in Patients With Myositis |
| Official title | An Open Trial With TNF Blockade With Infliximab (Remicade®), in Patients With Chronic Inflammatory Myopathies |
| Lead sponsor | Karolinska Institutet, Other |
| Collaborators | Schering-Plough Industry Medical Research Council |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Refractory Myositis |
| Intervention type | Drug |
| Interventions | Infliximab |
| First posted | Mar 5, 2007 |
| Last update posted | Mar 5, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: